Viral Hemorrhagic Fever Latest Advances

Effectiveness of Montelukast in Reducing the Risk of Severe Dengue in Dengue Fever Patients: An Evidence-Based Case Report.

Journal: Acta medica Indonesiana

Published: April 14, 2026

Reemergence of Yellow Fever, Magdalena Valley, Colombia, 2024-2025.

Journal: The Pediatric infectious disease journal

Published: April 13, 2026

CD8+ T cells and Humoral Immunity Influence the Development of Antibody-Dependent Enhancement: Implications for Vaccine Design.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Analysis of the Spatial Distribution Characteristics of the Peak Density of Rodents and Mosquitoes in the Main Urban Area of Hefei in 2024.

Journal: Vector borne and zoonotic diseases (Larchmont, N.Y.)

Published: April 10, 2026

Correction: In Silico and in vitro antiviral activity of FDA approved drugs from ZINC database against RNA-dependent RNA polymerase of dengue virus.

Journal: Virology journal

Published: April 10, 2026

Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.

Journal: The New England journal of medicine

Published: April 08, 2026

Investigation of and Response to Autochthonous Dengue, Los Angeles County, California, USA, August-November 2024.

Journal: Emerging infectious diseases

Published: April 06, 2026

Recombinant expression of rift valley fever virus nucleocapsid protein and generation of rabbit polyclonal antibodies

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: April 03, 2026

Pathogenicity of Rift Valley fever virus: Organ-specific clinical outcomes and hidden drivers of virulence - a narrative review.

Journal: Virulence

Published: April 03, 2026

Statement of Retraction: Impact of environmental factors on the spread of dengue fever in the United States of America (USA).

Journal: International journal of environmental health research

Published: April 02, 2026

Addressing the elephant in the room: Proceedings of the third annual Dengue Endgame Summit.

Journal: PLoS neglected tropical diseases

Published: April 01, 2026

Stability in a Two-Strain Dengue Model with a Constant Recruitment.

Journal: Nonlinear dynamics, psychology, and life sciences

Published: March 31, 2026

Viral Hemorrhagic Fever Latest Advances

Find the Latest Research About Viral Hemorrhagic Fever

Effectiveness of Montelukast in Reducing the Risk of Severe Dengue in Dengue Fever Patients: An Evidence-Based Case Report.

Effectiveness of Montelukast in Reducing the Risk of Severe Dengue in Dengue Fever Patients: An Evidence-Based Case Report.

Reemergence of Yellow Fever, Magdalena Valley, Colombia, 2024-2025.

Reemergence of Yellow Fever, Magdalena Valley, Colombia, 2024-2025.

CD8+ T cells and Humoral Immunity Influence the Development of Antibody-Dependent Enhancement: Implications for Vaccine Design.

CD8+ T cells and Humoral Immunity Influence the Development of Antibody-Dependent Enhancement: Implications for Vaccine Design.

Analysis of the Spatial Distribution Characteristics of the Peak Density of Rodents and Mosquitoes in the Main Urban Area of Hefei in 2024.

Analysis of the Spatial Distribution Characteristics of the Peak Density of Rodents and Mosquitoes in the Main Urban Area of Hefei in 2024.

Correction: In Silico and in vitro antiviral activity of FDA approved drugs from ZINC database against RNA-dependent RNA polymerase of dengue virus.

Correction: In Silico and in vitro antiviral activity of FDA approved drugs from ZINC database against RNA-dependent RNA polymerase of dengue virus.

Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.

Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial.

Investigation of and Response to Autochthonous Dengue, Los Angeles County, California, USA, August-November 2024.

Investigation of and Response to Autochthonous Dengue, Los Angeles County, California, USA, August-November 2024.

Recombinant expression of rift valley fever virus nucleocapsid protein and generation of rabbit polyclonal antibodies

Recombinant expression of rift valley fever virus nucleocapsid protein and generation of rabbit polyclonal antibodies

Pathogenicity of Rift Valley fever virus: Organ-specific clinical outcomes and hidden drivers of virulence - a narrative review.

Pathogenicity of Rift Valley fever virus: Organ-specific clinical outcomes and hidden drivers of virulence - a narrative review.

Statement of Retraction: Impact of environmental factors on the spread of dengue fever in the United States of America (USA).

Statement of Retraction: Impact of environmental factors on the spread of dengue fever in the United States of America (USA).

Addressing the elephant in the room: Proceedings of the third annual Dengue Endgame Summit.

Addressing the elephant in the room: Proceedings of the third annual Dengue Endgame Summit.

Stability in a Two-Strain Dengue Model with a Constant Recruitment.

Stability in a Two-Strain Dengue Model with a Constant Recruitment.